Article contents
Antidepressive effects of the selective MAO-inhibitor brofaromine:an open trial
Published online by Cambridge University Press: 16 April 2020
Summary
In an open prospective study, the antidepressive effects of the selective and reversible MAO-A inhibitor, brofaromine, were investigated in nine endogenous depressed patients, who had failed to respond to cyclic antidepressants. In three patients a clinically relevant improvement was observed, although for the total group, no statistically significant treatment effect could be demonstrated. In two subjects, postural hypotension and sleep disturbances occurred temporarily.
- Type
- Short communication
- Information
- Copyright
- Copyright © Elsevier, Paris 1992
References
- 1
- Cited by
Comments
No Comments have been published for this article.